236 related articles for article (PubMed ID: 26818872)
1. Dry Powder form of Polymeric Nanoparticles for Pulmonary Drug Delivery.
Shiehzadeh F; Tafaghodi M
Curr Pharm Des; 2016; 22(17):2549-60. PubMed ID: 26818872
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary drug delivery: a role for polymeric nanoparticles?
d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles for pulmonary protein and DNA delivery.
Menon JU; Ravikumar P; Pise A; Gyawali D; Hsia CC; Nguyen KT
Acta Biomater; 2014 Jun; 10(6):2643-52. PubMed ID: 24512977
[TBL] [Abstract][Full Text] [Related]
4. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
Rawal T; Parmar R; Tyagi RK; Butani S
Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
[TBL] [Abstract][Full Text] [Related]
6. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of inhalable nanoparticles: dry powder inhalers.
Al-Hallak MH; Sarfraz MK; Azarmi S; Roa WH; Finlay WH; Löbenberg R
Ther Deliv; 2011 Oct; 2(10):1313-24. PubMed ID: 22826885
[TBL] [Abstract][Full Text] [Related]
8. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N
Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555
[TBL] [Abstract][Full Text] [Related]
9. Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers.
Islam N; Richard D
Curr Cancer Drug Targets; 2019; 19(3):162-178. PubMed ID: 29793407
[TBL] [Abstract][Full Text] [Related]
10. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
Rawal T; Kremer L; Halloum I; Butani S
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
[TBL] [Abstract][Full Text] [Related]
11. Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition.
Djiokeng Paka G; Doggui S; Zaghmi A; Safar R; Dao L; Reisch A; Klymchenko A; Roullin VG; Joubert O; Ramassamy C
Mol Pharm; 2016 Feb; 13(2):391-403. PubMed ID: 26618861
[TBL] [Abstract][Full Text] [Related]
12. A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery.
Pasero L; Susa F; Limongi T; Pisano R
Int J Pharm; 2024 Jun; 659():124248. PubMed ID: 38782150
[TBL] [Abstract][Full Text] [Related]
13. Inhalable nanoparticulate powders for respiratory delivery.
Muralidharan P; Malapit M; Mallory E; Hayes D; Mansour HM
Nanomedicine; 2015 Jul; 11(5):1189-99. PubMed ID: 25659645
[TBL] [Abstract][Full Text] [Related]
14. Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler.
Salem HF; Kharshoum RM; Abdel Hakim LF; Abdelrahim ME
J Liposome Res; 2016 Dec; 26(4):324-35. PubMed ID: 26872552
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
16. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
Muralidharan P; Hayes D; Mansour HM
Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
[TBL] [Abstract][Full Text] [Related]
17. Poly(lactide-
Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
[TBL] [Abstract][Full Text] [Related]
18. Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline.
Rawal T; Patel S; Butani S
Eur J Pharm Sci; 2018 Nov; 124():273-287. PubMed ID: 30176365
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery.
Liu K; Chen W; Yang T; Wen B; Ding D; Keidar M; Tang J; Zhang W
Int J Nanomedicine; 2017; 12():8239-8255. PubMed ID: 29180863
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
